Top 10 Cognitive Screening and Assessment Tools

Cognitive screening can help identify changes in memory, attention, executive function, processing speed, and other cognitive abilities. As earlier identification becomes increasingly important and new biomarkers and treatments for Alzheimer's and other dementias become available, practices and healthcare organizations have more options for evaluating cognition than ever before.

There is no single cognitive screening tool that is right for every patient or clinical setting. A busy primary care practice may prioritize speed and simplicity, while a neurology or geriatrics practice may require a more comprehensive assessment. Health systems building population-level cognitive-care programs may place greater importance on digital administration, standardized scoring, EHR integration, care planning, population health analytics, and longitudinal monitoring.

Below are 10 leading cognitive screening and assessment tools, ranked based on a combination of clinical utility, evidence, breadth of assessment, ease of administration, scalability, and ability to support cognitive care beyond the initial test.

To break them down, we have each labeled for comparison:

• Simple Screener — a brief instrument that flags possible impairment and indicates whether further evaluation is needed

• Extended Assessment — a more detailed, multi-domain evaluation of cognitive performance

• Screening + Care Platform — technology that spans screening, assessment, interpretation, and ongoing care planning within a single workflow

1. BrainCheck

Category: Screening + Care Platform
Format: Digital platform requiring adoption
Administration Time: Screen ≈ 3 minutes; Assess ≈ 15 minutes
Best Fit: Primary care, neurology, behavioral health practices, and health systems

Best overall: Screening, assessment, and care planning in one integrated cognitive-care platform

Rather than providing a single point-in-time test, BrainCheck is a digital cognitive assessment and care plan platform designed to support patients from initial identification through screening, assessment, interpretation, care planning, and longitudinal follow-up.

Established clinical adoption

BrainCheck is used across more than 500 healthcare organizations, spanning primary care, geriatrics, neurology, behavioral health, and academic research, including Cleveland Clinic, UPMC, Bon Secours, and Springfield Clinic, and by more than 100 neurologists.

Clinical evidence

BrainCheck grounds itself in clinical rigor, including 39 peer-reviewed publications, academic research collaborations, and a 5,000-patient normative database. Published research has demonstrated that BrainCheck Assess has sensitivity of 86% for mild cognitive impairment and 88% for dementia, and specificity of 83% for mild cognitive impairment and 94% for dementia.

Strengths

• End-to-end cognitive assessment and care platform, rather than a standalone cognitive test, spanning identification, screening, assessment, interpretation, care planning, and longitudinal monitoring
• Population Analytics helps proactively identify and prioritize patients for clinician review, using existing EHR data, rather than relying solely on opportunistic in-visit screening
• BrainCheck Assess is an FDA Class II medical device
• Objective, automatically scored digital assessment across five cognitive domains
• Clinicians can build custom protocols and incorporate 30+ additional clinical evaluation tools, including GAD7, GDS, RUDAS, and SLUMs
• Reduces manual scoring and standardizes assessment workflows

Limitations

• Can be more comprehensive than necessary when a clinician only wants a simple two- or three-minute screen
• Requires adoption of a digital platform, not paper-based
• Population Analytics organizes EHR data for clinician review; it does not diagnose or generate clinical risk scores itself
• Results require appropriate clinical interpretation and are not a standalone diagnosis

BrainCheck is made for practices and health systems seeking to build a scalable cognitive-care program, rather than administer an isolated cognitive test, to support a proactive approach to cognitive care.

Learn more: braincheck.com

2. Montreal Cognitive Assessment (MoCA)

Category: Extended Assessment
Format: Traditional paper-based, clinician-administered screen
Administration Time: ≈ 10 minutes
Best Fit: Primary care, neurology, or geriatrics practices

Best for: Widely recognized clinician-administered screening for mild cognitive impairment

The Montreal Cognitive Assessment, or MoCA, is one of the world's most widely recognized cognitive screening instruments. The standard MoCA takes approximately 10 minutes and evaluates multiple areas of cognition, including short-term memory, visuospatial abilities, executive function, attention, working memory, language, and orientation.

MoCA has been extensively studied and is particularly well known for its use in detecting mild cognitive impairment. It is a standalone screener; it does not include care planning or longitudinal workflow tools.

Strengths

• Extensive clinical and research history
• Widely recognized by physicians
• Evaluates multiple cognitive domains
• Particularly established for mild cognitive impairment screening
• Available in numerous languages
• Strong sensitivity for MCI
• Multiple versions available for different populations and settings
• Relatively inexpensive compared with comprehensive digital platforms

Limitations

• Requires trained administration
• Certification requirements apply to many users
• Typically consumes clinician or staff time
• Manual administration can make large-scale deployment more difficult
• Can exhibit lower specificity
• Not end-to-end cognitive-care
• Traditional administration provides limited workflow, care-planning, and longitudinal infrastructure

Learn more: mocacognition.com

3. Mini-Cog

Category: Simple Screener
Format: Traditional (paper/verbal, clinician-administered)
Administration Time: ≈ 3 minutes
Best Fit: Busy primary care or urgent care settings

Best for: Very rapid cognitive screening in primary care

Mini-Cog combines three-word recall with a clock-drawing task and can generally be completed in approximately three minutes. Its simplicity has made it particularly useful in primary care and other settings where clinicians need to identify patients who may warrant additional cognitive evaluation without significantly disrupting the visit.

Strengths

• Approximately three minutes
• Simple administration
• No special equipment required
• Low implementation burden
• Useful as an initial screen

Limitations

• Limited depth
• Provides relatively little information about individual cognitive domains
• Positive results generally require additional assessment
• Less useful for characterizing subtle cognitive impairment
• Limited longitudinal measurement capabilities
• Does not provide an integrated pathway into interpretation or care planning

Learn more: mini-cog.com

4. SLUMS — Saint Louis University Mental Status Examination

Category: Extended Assessment
Format: Traditional paper-based, clinician-administered
Administration Time: ≈ 7–10 minutes
Best Fit: Primary care or settings wanting a free, relatively comprehensive paper screen

Best for: Traditional multidomain cognitive screening

The Saint Louis University Mental Status Examination, commonly known as SLUMS, is a clinician-administered screening instrument designed to identify cognitive impairment. It evaluates areas including orientation, memory, attention, executive function, and visuospatial ability.

SLUMS provides clinicians with a relatively comprehensive traditional cognitive screen without requiring specialized digital technology. Like other paper-based instruments on this list, it is a standalone tool.

Strengths

• Evaluates multiple cognitive domains
• Relatively straightforward administration
• Familiar paper-based format
• Can identify milder cognitive impairment
• Low technology requirements
• Established clinical use, and free to administer

Limitations

• Requires staff administration and scoring
• Primarily paper-based
• Less suited to automated, population-scale screening
• Limited workflow automation
• Limited longitudinal analytics compared with digital platforms
• Does not inherently connect screening to care planning

Learn more: SLU School of Medicine — SLUMS Exam

5. Linus Health

Category: Screening + Care Platform
Format: Digital platform/device requiring adoption.
Administration Time: ≈8 minutes for Core Cognitive Evaluation™, ≈2-3 minutes for DCTClock and DCR
Best Fit: Neurology practices, memory clinics, and clinical-trial settings

Best for: Digital analysis of subtle aspects of clock-drawing performance

Linus Health's current flagship product is the Core Cognitive Evaluation™ (CCE), which pairs Digital Clock and Recall ( DCR™) — clock drawing plus immediate and delayed word recall — with a Life and Health Questionnaire covering broader dementia risk factors. Both are powered by DCTClock™, the company's underlying AI engine, which analyzes how a patient draws, not just the finished clock, to surface subtle impairment traditional scoring can miss.

Beyond the assessment itself, the platform generates clinical decision support and personalized patient action plans, supports longitudinal monitoring through EHR integration, and, for payer and health-system clients, uses a predictive engine (Radar) to analyze claims and clinical data and flag at-risk members before they're ever screened.

Strengths

• Personalized action plans and clinical decision support generated alongside every assessment
• Radar engine identifies at-risk patients from claims/clinical data before screening, for payer and health-system deployments
• Captures process-level detail traditional scoring misses, via AI analysis of the clock-drawing task
• Fast (≈2–3 minutes for DCR™) and administrable by staff without specialized training
• Designed for scalable clinical workflows

Limitations

• Proprietary commercial platform
• Requires digital platform adoption
• Less universally familiar to clinicians than long-established paper-based tools
• Clock-based methodology provides different information from a broader multidomain cognitive battery
• Does not by itself represent a complete cognitive-care pathway

Learn more: linushealth.com/our-assessments

6. Cognivue

Category: Extended Assessment
Format: Digital device with dedicated proprietary hardware requiring purchase or lease.
Administration Time: Cognivue Thrive® ≈ 5 minutes; Cognivue Clarity® ≈ 10 minutes
Best Fit: Practices wanting self-administered, standardized testing and willing to invest in dedicated equipment

Best for: Self-administered, FDA-cleared computerized cognitive testing

Cognivue provides computerized cognitive assessment technology designed to reduce the staff burden associated with traditional cognitive testing. Cognivue assessments are self-administered using a dedicated device. The platform evaluates cognitive areas including memory, executive function, attention, discrimination, and visuospatial performance.

Strengths

• FDA-cleared as an adjunctive cognitive assessment aid
• Self-administered
• Test time is 5-10 minutes
• Automated scoring
• Standardized testing experience
• Reduces staff administration burden
• Evaluates multiple cognitive areas
• Well suited to practices willing to adopt dedicated cognitive-testing equipment

Limitations

• Requires proprietary hardware
• Must administer on a dedicated device
• Commercial implementation cost
• Requires physical deployment of equipment
• Results still require clinical interpretation
• Primarily focused on assessment rather than end-to-end cognitive care

Learn more: cognivue.com

7. Creyos

Category: Screening + Care Platform
Format: Digital platform requiring a subscription adoption
Administration Time: Brief screener ≈ 5 minutes; full battery ≈ 30 minutes
Best Fit: Primary care, neurology, and behavioral health practices

Best for: Detailed web-based cognitive-domain measurement

Creyos, formerly Cambridge Brain Sciences, provides web-based cognitive assessments covering areas such as memory, reasoning, concentration, and verbal ability. The underlying cognitive tasks have a substantial academic research history and can be administered digitally, either in a clinical environment or remotely.

Creyos can be particularly useful when clinicians or researchers want more detailed domain-specific cognitive information. Care-planning tools are a newer addition to the platform, not the original core design, which was built around detailed cognitive measurement.

Strengths

• Fully digital
• Self-administered
• Strong research heritage
• Detailed cognitive-domain information
• Remote and in-clinic administration
• Automated scoring
• Applicable across several neurological and behavioral-health use cases
• Care planning

Limitations

• Can be more comprehensive than necessary for simple dementia screening
• Requires adoption of platform
• Total time for testing longer than ultra-brief screeners
• Newer to primary-care adoption than legacy paper-based screening tools
• Detailed results may provide more information than clinicians need for a simple initial screen

Learn more: creyos.com

8. GPCOG — General Practitioner Assessment of Cognition

Category: Simple Screener
Format: Traditional paper-based; web-based version also available, clinician-administered
Administration Time: ≈ 4 minutes (patient) plus ≈ 2 minutes (informant, if needed) — under 5 minutes total
Best Fit: Primary care practices wanting a quick screen that also captures real-world functional context

Best for: Primary-care screening incorporating an informant

The General Practitioner Assessment of Cognition was developed specifically for primary-care physicians. An important feature of GPCOG is its ability to combine direct patient testing with information from someone who knows the patient well. This can be valuable because dementia involves not only cognitive-test performance but changes in everyday functioning. Like other brief screeners on this list, it is a standalone instrument.

Strengths

• Specifically designed for primary care
• 4-6 minutes total
• Includes an informant component
• Available in multiple languages
• Free to complete online, with informant present
• Considers real-world functional change
• Minimal technology requirements, option to be done manually or digitally

Limitations

• Informant may not always be available
• Less detailed cognitive-domain information
• Primarily a screening instrument
• Manual workflows can limit population-scale deployment
• Subjective informant information can influence results
• Additional assessment is needed after a positive screen

Learn more: gpcog.com.au

9. AD8

Category: Simple Screener
Format: Traditional paper/verbal and self- or informant-administered.
Administration Time: ≈ 3 minutes
Best Fit: Primary care practices wanting a pre-visit screen completed by the patient or a caregiver

Best for: Identifying cognitive change through patient or informant observations

AD8 is a brief eight-question screening interview that focuses on whether there has been a meaningful change from an individual's previous level of functioning. Questions address areas such as judgment, interests, learning to use new devices, handling finances, remembering appointments, and everyday thinking and memory.

This makes AD8 quite different from performance-based cognitive tests and potentially useful as a complementary measure. It flags possible change but does not perform cognitive testing itself, and has no built-in assessment or care-planning component.

Strengths

• Approximately 3 minutes
• Simple to administer
• Focuses on change from the person's previous cognitive function
• Can incorporate information from someone who knows the patient
• Paper/pencil or digital administration
• Useful alongside objective cognitive testing
• Practical for initial case finding

Limitations

• Subjective questionnaire
• Dependent on the quality of patient or informant reporting
• Does not directly measure cognitive performance
• Limited domain-specific information
• Positive findings require further evaluation
• Not designed for detailed longitudinal cognitive measurement

Learn more: Alzheimer's Association — Cognitive Assessment Tools

10. Mini-Mental State Examination, Second Edition (MMSE-2)

Category: Extended Assessment
Format: Traditional paper-based, clinician-administered, licensed.
Administration Time: Brief ≈ 5 minutes; Standard ≈ 10–15 minutes; Expanded longer, with added subtests
Best Fit: Practices wanting continuity with decades of prior MMSE results, or long-standing clinician familiarity with the instrument

Best for: Clinical familiarity and historical comparison

The Mini-Mental State Examination is one of the most historically recognizable cognitive tests. The MMSE-2 maintains the familiar approach while offering Brief, Standard, and Expanded versions. The Standard version generally takes approximately 10–15 minutes.

Its greatest advantage may be familiarity: generations of clinicians have used the MMSE, and its scoring system is widely understood. It remains a standalone cognitive test.

Strengths

• Decades of clinical familiarity
• Extensive historical research
• Simple scoring
• Three versions (Brief, Standard, and Expanded)
• Multiple translations
• Useful when comparing patients with historical MMSE results
• Familiar to many physicians

Limitations

• Proprietary and licensed
• The Brief and Standard versions lack depth for detecting earlier decline
• Requires clinician or staff administration
• Limited digital functionality in traditional use
• The Standard version offers limited domain-level detail.
• Primarily a cognitive test rather than a broader cognitive-care platform

Learn more: PAR — MMSE-2

There is no single correct answer when it comes to choosing a cognitive screening or assessment tool — the right choice depends on a practice's setting, patient population, and workflow.

However, as cognitive care shifts toward more proactive, longitudinal models, tools that support the full pathway — from identification through screening, assessment, care planning, and follow-up — can make that shift easier to operationalize at scale. BrainCheck is one example of that full cognitive care pathway built into one platform.